Molecular dosimetry of hepatic aflatoxin B1-DNA adducts: Linear correlation with hepatic cancer risk
Author:
- 1 August 1989
- journal article
- research article
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 10 (1) , 74-81
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Quantitative inter-relationships between aflatoxin B1 carcinogen dose, indole-3-carbinol anti-carcinogen dose, target organ DNA adduction and final tumor responseCarcinogenesis, 1989
- Mechanisms of anti-carcinogenesis by indole-3-carbinol: detailed in vivo DNA binding dose-response studies after dietary administration with aflatoxin B1Carcinogenesis, 1988
- The Molecular Dosimetry of DNA Adducts Formed by Continuous Exposure of Rats to Alkylating Hepatocarcinogens1987
- Quantitative evaluation of DNA binding data for risk estimation and for classification of direct and indirect carcinogensJournal of Cancer Research and Clinical Oncology, 1986
- Hepatocellular carcinoma and dietary aflatoxin in Mozambique and TranskeiBritish Journal of Cancer, 1985
- Effect of dose on the inhibition of carcinogenesis/mutagenesis by aroclor 1254 in rainbow trout fed aflatoxin B1Journal of Toxicology and Environmental Health, 1984
- Aflatoxin as a cause of primary liver‐cell cancer in the United States: A probability studyNutrition and Cancer, 1983
- Effect of Cyclopropenoid Compounds on the Carcinogenic Activity of Diethylnitrosamine and Aflatoxin B in Rats 2 3JNCI: Journal of the National Cancer Institute, 1974
- 2,3-Dihydro-2,3-dihydroxy-aflatoxin B1: An acid hydrolysis product of an RNA-aflatoxin B1 adduct formed by hamster and rat liver microsomes in vitroBiochemical and Biophysical Research Communications, 1973
- Metabolism as a factor in determining the toxic action of the aflatoxins in different animal speciesFood and Cosmetics Toxicology, 1973